FDA Raises Questions Over Antibacterial Soaps

FDA Raises Questions Over Antibacterial Soaps

Federal regulators are asking makers of antibacterial soaps“to prove they are not only better but also that they are safe.” Sandra Kweder, deputy director of the FDA’s Office of New Drugs, says, “We have no evidence that presence of the anti-bacterial ingredients in these soaps and body washes actually prevent the spread of infection.”Authorities are concerned that the liquid soaps “which contain triclosan or triclocarban may potentially interfere with hormones like estrogen, testosterone and thyroid functions,” and ultimately affect “childhood development and puberty.” Criticism of antibacterial soaps have focused mainly on three allegations: that theyare no better than regular soaps in fighting germs; that they contain compounds that may induce hormonal changes in humans, for instance; and that they give rise to a new breed of antibiotic-resistant germs. The FDA “has given companies a year to produce data showing that the chemicals are both safe and effective. If they cannot prove, the chemicals will need to be removed from the products.

By | 2018-09-27T11:20:02+00:00 March 13th, 2014|News|0 Comments

Leave A Comment

CallEmail GalleryDirections
Call